Nasdaq · Healthcare
AdaptHealth Corp. (AHCO)
As-reported financials and recent SEC filings for AdaptHealth Corp., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$3.24B
Net income
$-70.8M
Net margin
-2.2%
Diluted EPS
$-0.52
ROE
-4.6%
P/E (TTM)
—
Market cap
$1.40B
Debt / equity
1.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.24B | $3.26B | $3.20B | $2.97B | $2.45B |
| Gross profit | $609.2M | $681.1M | $624.1M | $580.1M | $445.6M |
| Operating income | $90.9M | $263.7M | $-598.4M | $190.4M | $225.6M |
| Net income | $-70.8M | $90.4M | $-678.9M | $69.3M | $156.2M |
| Diluted EPS | $-0.52 | $0.61 | $-5.31 | $0.33 | $0.67 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →Go deeper on AHCO
Search AdaptHealth Corp.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.